John N.D. Wurpel

1.5k total citations · 1 hit paper
51 papers, 1.2k citations indexed

About

John N.D. Wurpel is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, John N.D. Wurpel has authored 51 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 16 papers in Oncology and 14 papers in Cellular and Molecular Neuroscience. Recurrent topics in John N.D. Wurpel's work include Neuroscience and Neuropharmacology Research (14 papers), Cancer therapeutics and mechanisms (13 papers) and Drug Transport and Resistance Mechanisms (13 papers). John N.D. Wurpel is often cited by papers focused on Neuroscience and Neuropharmacology Research (14 papers), Cancer therapeutics and mechanisms (13 papers) and Drug Transport and Resistance Mechanisms (13 papers). John N.D. Wurpel collaborates with scholars based in United States, China and Jamaica. John N.D. Wurpel's co-authors include Solomon L. Moshé, Ellen F. Sperber, Zhe‐Sheng Chen, Zi‐Ning Lei, Qiu‐Xu Teng, Walter B. Severs, Yihang Pan, Pranav Gupta, Leli Zeng and Tian Qin and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

John N.D. Wurpel

51 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Understanding and targeting resistance mechanisms in cancer

2023 177 citations Zi‐Ning Lei, Tian Qin et al. SHILAP Revista de lepidopterología profile →

Peers

Countries citing papers authored by John N.D. Wurpel

Since Specialization

Citations

This map shows the geographic impact of John N.D. Wurpel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John N.D. Wurpel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John N.D. Wurpel more than expected).

Fields of papers citing papers by John N.D. Wurpel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John N.D. Wurpel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John N.D. Wurpel. The network helps show where John N.D. Wurpel may publish in the future.

Co-authorship network of co-authors of John N.D. Wurpel

This figure shows the co-authorship network connecting the top 25 collaborators of John N.D. Wurpel. A scholar is included among the top collaborators of John N.D. Wurpel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John N.D. Wurpel. John N.D. Wurpel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combating antimicrobial resistance: the silent war 2024 ·Frontiers in Pharmacology ·Letao Bo, Haidong Sun, Yidong Li, (unknown), John N.D. Wurpel, (unknown), Zhe‐Sheng Chen	16
2	Cancer vaccines in focus: The next frontier in immuno-oncology 2024 ·Cancer Letters ·Yuhao Xie, (unknown), (unknown), John N.D. Wurpel, Zhe‐Sheng Chen	1
3	ABCB1-dependent collateral sensitivity of multidrug-resistant colorectal cancer cells to the survivin inhibitor MX106-4C 2024 ·Drug Resistance Updates ·Zi‐Ning Lei, Najah Albadari, (unknown), (unknown), Jing‐Quan Wang, Zhongzhi Wu, Dejian Ma, Suresh V. Ambudkar, John N.D. Wurpel, Yihang Pan, Wěi Li, Zhe‐Sheng Chen	15
4	Understanding and targeting resistance mechanisms in cancer breakdown → 2023 ·SHILAP Revista de lepidopterología ·Zi‐Ning Lei, Tian Qin, Qiu‐Xu Teng, John N.D. Wurpel, Leli Zeng, Yihang Pan, Zhe‐Sheng Chen	177
5	The Battlefield of Chemotherapy in Pediatric Cancers 2023 ·Cancers ·Letao Bo, Youyou Wang, Yidong Li, John N.D. Wurpel, Zoufang Huang, Zhe‐Sheng Chen	16
6	Overexpression of ABCC1 and ABCG2 confers resistance to talazoparib, a poly (ADP-Ribose) polymerase inhibitor 2023 ·Drug Resistance Updates ·Qiu‐Xu Teng, Zi‐Ning Lei, Jing‐Quan Wang, Yuqi Yang, Zhuo‐Xun Wu, (unknown), Wei Zhang, Sabesan Yoganathan, Yihang Pan, John N.D. Wurpel, Zhe‐Sheng Chen, Shuo Fang	16
7	Overcoming multidrug resistance by knockout of ABCB1 gene using CRISPR/Cas9 system in SW620/Ad300 colorectal cancer cells 2021 ·SHILAP Revista de lepidopterología ·Zi‐Ning Lei, Qiu‐Xu Teng, Zhuo‐Xun Wu, Fengfeng Ping, Peng Song, John N.D. Wurpel, Zhe‐Sheng Chen	36
8	BMS-599626, a Highly Selective Pan-HER Kinase Inhibitor, Antagonizes ABCG2-Mediated Drug Resistance 2020 ·Cancers ·(unknown), (unknown), Pranav Gupta, (unknown), Zi‐Ning Lei, Sandra E. Reznik, Sabrina Lusvarghi, John N.D. Wurpel, Suresh V. Ambudkar, Zhe‐Sheng Chen	13
9	Establishment and Characterization of a Topotecan Resistant Non-small Cell Lung Cancer NCI-H460/TPT10 Cell Line 2020 ·Frontiers in Cell and Developmental Biology ·Zi‐Ning Lei, Qiu‐Xu Teng, Wei Zhang, Yingfang Fan, Jing‐Quan Wang, Chao‐Yun Cai, Kimberly Lu, Dong‐Hua Yang, John N.D. Wurpel, Zhe‐Sheng Chen	18
10	Epidermal growth factor receptor (EGFR) inhibitor PD153035 reverses ABCG2-mediated multidrug resistance in non-small cell lung cancer: In vitro and in vivo 2018 ·Cancer Letters ·Guan-Nan Zhang, Yunkai Zhang, Yi‐Jun Wang, Pranav Gupta, Charles R. Ashby, Saeed Alqahtani, (unknown), Susan E. Bates, Amal Kaddoumi, John N.D. Wurpel, Yixiong Lei, Zhe‐Sheng Chen	48
11	Modulating the function of ATP-binding cassette subfamily G member 2 (ABCG2) with inhibitor cabozantinib 2017 ·Pharmacological Research ·Guan-Nan Zhang, Yunkai Zhang, Yi‐Jun Wang, (unknown), (unknown), Xinyue Yu, (unknown), John N.D. Wurpel, Zhe‐Sheng Chen	30
12	Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance 2014 ·Molecules ·Nagaraju Anreddy, Pranav Gupta, Rishil J. Kathawala, Atish Patel, John N.D. Wurpel, Zhe‐Sheng Chen	90
13	PD173074, a selective FGFR inhibitor, reverses MRP7 (ABCC10)-mediated MDR 2014 ·Acta Pharmaceutica Sinica B ·Nagaraju Anreddy, Atish Patel, Kamlesh Sodani, Rishil J. Kathawala, (unknown), John N.D. Wurpel, Zhe‐Sheng Chen	26
14	Calcium Channel Blockers Verapamil and Nimodipine Inhibit Kindling in Adult and Immature Rats 1994 ·Epilepsia ·John N.D. Wurpel, Shridhar N. Iyer	45
15	Baclofen prevents rapid amygdala kindling in adult rats 1994 ·Cellular and Molecular Life Sciences ·John N.D. Wurpel	15
16	Structure-Activity Study of 5-Substituted 1-Carbobenzoxy-2-iminohydantoins as Potential Anticonvulsant Agents 1994 ·Journal of Medicinal Chemistry ·(unknown), Chul‐Hoon Kwon, John N.D. Wurpel	20
17	Baclofen inhibits amygdala kindling in immature rats 1990 ·Epilepsy Research ·John N.D. Wurpel, Ellen F. Sperber, Solomon L. Moshé	17
18	Age-related changes of muscimol binding in the substantia nigra 1988 ·Developmental Brain Research ·John N.D. Wurpel, Ann Tempel, Ellen F. Sperber, Solomon L. Moshé	24
19	Regional Cerebral Glucose Utilization during Vasopressin-Induced Barrel Rotations or Bicuculline-Induced Seizures in Rats 1988 ·Pharmacology ·John N.D. Wurpel, Ronald L. Dundore, Robert M. Bryan, L. C. Keil, Walter B. Severs	13
20	Nigral infusions of muscimol or bicuculline facilitate seizures in developing rats 1987 ·Developmental Brain Research ·Ellen F. Sperber, Bowen Y. Wong, John N.D. Wurpel, Solomon L. Moshé	52

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact